Literature DB >> 16317987

Cardiovascular disease event classification in the Jackson Heart Study: methods and procedures.

Emmanuel Keku1, Wayne Rosamond, Herman A Taylor, Robert Garrison, Sharon B Wyatt, Michelle Richard, Brenda Jenkins, Lisa Reeves, Daniel Sarpong.   

Abstract

OBJECTIVE: The process of identifying, abstracting, and classifying cardiovascular disease (CVD) endpoints in the Jackson Heart Study (JHS) is described.
METHOD: Trained interviewers conduct telephone annual followup interviews on or near the JHS exam 1 anniversary to ascertain any significant health events since the last JHS contact, including diagnostic tests, hospitalizations, or death. Information on cohort hospitalizations and deaths is transmitted to the medical record abstraction (MRA) unit who review death certificates and hospital records to identify CVD events in the cohort. Interviews with the next of kin and completed questionnaires by physicians and medical examiners or coroners are used to obtain information on deaths in the cohort. A computer-generated diagnosis with follow-up review and adjudication by trained medical personnel completes final, disease-specific event classification of hospitalized and fatal coronary heart disease (CHD), stroke, and congestive heart failure (CHF) events. DISCUSSION: Surveillance of this well-characterized group of African Americans for CVD events as well as sub- and preclinical manifestations of disease is a central aspect of the JHS. Particular focus is placed on the leading causes of CVD illness and death, including fatal and nonfatal CHD, stroke, and CHF.

Entities:  

Mesh:

Year:  2005        PMID: 16317987

Source DB:  PubMed          Journal:  Ethn Dis        ISSN: 1049-510X            Impact factor:   1.847


  84 in total

1.  Risk of Ischemic Stroke Increases Over the Spectrum of Metabolic Syndrome Severity.

Authors:  Mark D DeBoer; Stephanie L Filipp; Mario Sims; Solomon K Musani; Matthew J Gurka
Journal:  Stroke       Date:  2020-06-19       Impact factor: 7.914

2.  Development and Validation of Risk Prediction Models for Cardiovascular Events in Black Adults: The Jackson Heart Study Cohort.

Authors:  Ervin R Fox; Tandaw E Samdarshi; Solomon K Musani; Michael J Pencina; Jung Hye Sung; Alain G Bertoni; Vanessa Xanthakis; Pelbreton C Balfour; Satya S Shreenivas; Carolyn Covington; Philip R Liebson; Daniel F Sarpong; Kenneth R Butler; Thomas H Mosley; Wayne D Rosamond; Aaron R Folsom; David M Herrington; Ramachandran S Vasan; Herman A Taylor
Journal:  JAMA Cardiol       Date:  2016-04-01       Impact factor: 14.676

3.  Incident Cardiovascular Disease Among Adults With Blood Pressure <140/90 mm Hg.

Authors:  Gabriel S Tajeu; John N Booth; Lisandro D Colantonio; Rebecca F Gottesman; George Howard; Daniel T Lackland; Emily C O'Brien; Suzanne Oparil; Joseph Ravenell; Monika M Safford; Samantha R Seals; Daichi Shimbo; Steven Shea; Tanya M Spruill; Rikki M Tanner; Paul Muntner
Journal:  Circulation       Date:  2017-06-20       Impact factor: 29.690

4.  Pulmonary Hypertension Is Associated With a Higher Risk of Heart Failure Hospitalization and Mortality in Patients With Chronic Kidney Disease: The Jackson Heart Study.

Authors:  Senthil Selvaraj; Sanjiv J Shah; Mark J Ommerborn; Cheryl R Clark; Michael E Hall; Robert J Mentz; Saadia Qazi; Jeremy M Robbins; Thomas N Skelton; Jiaying Chen; J Michael Gaziano; Luc Djoussé
Journal:  Circ Heart Fail       Date:  2017-06       Impact factor: 8.790

5.  Masked Hypertension and Cardiovascular Disease Events in a Prospective Cohort of Blacks: The Jackson Heart Study.

Authors:  John N Booth; Keith M Diaz; Samantha R Seals; Mario Sims; Joseph Ravenell; Paul Muntner; Daichi Shimbo
Journal:  Hypertension       Date:  2016-06-27       Impact factor: 10.190

6.  Association of Cardiac Injury and Malignant Left Ventricular Hypertrophy With Risk of Heart Failure in African Americans: The Jackson Heart Study.

Authors:  Ambarish Pandey; Neil Keshvani; Colby Ayers; Adolfo Correa; Mark H Drazner; Alana Lewis; Carlos J Rodriguez; Michael E Hall; Ervin R Fox; Robert J Mentz; Christopher deFilippi; Stephen L Seliger; Christie M Ballantyne; Ian J Neeland; James A de Lemos; Jarett D Berry
Journal:  JAMA Cardiol       Date:  2019-01-01       Impact factor: 14.676

7.  Leukocyte telomere length and cardiovascular disease in African Americans: The Jackson Heart Study.

Authors:  Stanford Mwasongwe; Yan Gao; Michael Griswold; James G Wilson; Abraham Aviv; Alexander P Reiner; Laura M Raffield
Journal:  Atherosclerosis       Date:  2017-09-15       Impact factor: 5.162

8.  Life Course Socioeconomic Status, Allostatic Load, and Kidney Health in Black Americans.

Authors:  Joseph Lunyera; John W Stanifer; Clemontina A Davenport; Dinushika Mohottige; Nrupen A Bhavsar; Julia J Scialla; Jane Pendergast; L Ebony Boulware; Clarissa Jonas Diamantidis
Journal:  Clin J Am Soc Nephrol       Date:  2020-02-19       Impact factor: 8.237

9.  Subclinical Atherosclerosis, Statin Eligibility, and Outcomes in African American Individuals: The Jackson Heart Study.

Authors:  Ravi V Shah; Aferdita Spahillari; Stanford Mwasongwe; J Jeffrey Carr; James G Terry; Robert J Mentz; Daniel Addison; Udo Hoffmann; Jared Reis; Jane E Freedman; Joao A C Lima; Adolfo Correa; Venkatesh L Murthy
Journal:  JAMA Cardiol       Date:  2017-06-01       Impact factor: 14.676

10.  Relations between subclinical disease markers and type 2 diabetes, metabolic syndrome, and incident cardiovascular disease: the Jackson Heart Study.

Authors:  Vanessa Xanthakis; Jung Hye Sung; Tandaw E Samdarshi; Alethea N Hill; Solomon K Musani; Mario Sims; Kamel A Ghraibeh; Philip R Liebson; Herman A Taylor; Ramachandran S Vasan; Ervin R Fox
Journal:  Diabetes Care       Date:  2015-03-12       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.